That’s why we pay LC the big bucks. She is all over this stuff. If you take a look at this recent slide it clearly shows the current strategy that’s upsetting the bedwetters !
IMU will have 3 programs all running PH2 trials in 2025. So she has made the decision not to do frivolous data cuts which are expensive and cause delays , which in turn waste money.
That would be wasteful doing this for retail punters who would only dump their shares anyway, To open ph2 trials she will do a full trial results announcement from the ph1 trials Big Pharma and Big Money want to see this data.
Do our pipeline will be on full display with accompanying data in 2025.
IMU Price at posting:
3.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)